Steven DeKosky

Lancet Neurology · 2002–2018

A researcher in the Science corpus: 21 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Who trusts Steven DeKosky overall

Papers from Steven DeKosky's perspective

Ordered by how strongly the researchers Steven DeKosky trusts endorse each paper. Same corpus, a different order for every researcher.

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. (Archives of Neurology)
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis (Science)
PET imaging of amyloid deposition in patients with mild cognitive impairment. (Neurobiology of Aging)
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration (Acta Neuropathologica)
PET of brain amyloid and tau in mild cognitive impairment. (New England Journal of Medicine)
Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B (Journal of Cerebral Blood Flow and Metabolism)
Quantifying heterogeneity in a meta‐analysis (Statistics in Medicine)
A new look at the statistical model identification
Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. (Journal of Medicinal Chemistry)

Their papers

Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) — 1,887 citations
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease (2009) — 740 citations
Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery—2018 (2018) — 1,240 citations
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. (2014) — 3,079 citations
The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease (2011) — 9,421 citations
APOE and Alzheimer disease: a major gene with semi-dominant inheritance (2011) — 679 citations
Revising the definition of Alzheimer's disease: a new lexicon. (2010) — 1,937 citations
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (2010) — 595 citations
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly (2008) — 1,100 citations
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease (2008) — 959 citations
Ginkgo biloba for Prevention of Dementia: A Randomized Controlled Trial (2008) — 659 citations
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. (2007) — 4,401 citations
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment (2007) — 790 citations
[11C]PIB in a nondemented population (2006) — 687 citations
Potential antecedent marker of Alzheimer disease (2006) — 641 citations
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans (2006) — 946 citations
Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B (2005) — 718 citations
CHRONIC TRAUMATIC ENCEPHALOPATHY IN A NATIONAL FOOTBALL LEAGUE PLAYER: PART II (2005) — 625 citations
Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. (2003) — 652 citations
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. (2002) — 2,080 citations